Innovation Frontier
Innovation Frontier
Cellular-level Anti-Aging
Cellular-level Anti-Aging
Cellular-level Anti-Aging
The extracellular matrix (ECM)
Cell Communication
Cells
Cellular-level Anti-Aging
The extracellular matrix (ECM)
Cell Communication
Cells
The extracellular matrix (ECM)
The extracellular matrix (ECM) acts as the "soil" for cell growth. It plays a vital role in maintaining tissue structure, regulating cellular behaviors and transmitting cellular signals. In 2025, a new review published in the journal Cell listed changes in the extracellular matrix as the 13th hallmark of aging.

Hyaluronic acid (HA) is a core component of the extracellular matrix. Leveraging precision fermentation technology based on synthetic biology, Bloomage Biotech produces hyaluronic acid with various molecular weights. Different molecular weights of HA transmit distinct cellular signals, regulate cell differentiation, relieve inflammation and promote tissue repair.
Cell Communication
Cell communication serves as the "social network" of cells. It is essential for maintaining tissue homeostasis and coordinating physiological functions. Disorders in cell communication will impair the function of local tissues and may even affect the aging process of the whole body via systemic effects.

Bloomage Biotech has developed a series of ingredients for cellular metabolism and signal regulation. Based on in-depth understanding of cell behavior modulation, we have also developed serum-free cell culture media, enabling the high-activity and controllable culture of mesenchymal stem cells and other cell types.
Cells
Cells are the fundamental units of life. Abnormalities in various intracellular functions are the most direct and core manifestations of cellular senescence. Cellular senescence refers not merely to cell division arrest, but more importantly, to the disorder and changes of intracellular functions.


Bloomage Biotech develops active ingredients that target mitochondria and gene expression. By regulating the expression of specific genes and boosting cellular energy, these ingredients directly slow down cellular senescence. We have established 3D skin models that simulate skin conditions such as wound healing, senescence and glycation. Serving as highly efficient efficacy testing platforms, these models fully replicate the multi-layer structure of human skin for the evaluation of bioactive substances.
Functions of Glycans
Functions of Glycans
Glycans contain more potential biological information than nucleic acids and proteins combined.
Functions of Glycans
Cell Recognition & Signal Transduction
Glycans on the cell surface act as unique "identification tags", enabling cells to accurately distinguish self-cells from foreign pathogens. For instance, in the immune system, immune cells recognize non-self substances via surface glycans and subsequently initiate immune responses to eliminate pathogens.

Glycans regulate the activity of cell surface receptors and the efficiency of signal transduction. When signaling molecules bind to receptor proteins, glycans intervene in this process, thereby modulating a full range of cellular activities including cell proliferation, differentiation and apoptosis.
Cell Structure & Stability Maintenance
On the cell membrane, glycans bind with lipids and proteins to form glycolipids and glycans. The outward-extending glycan chains constitute the cell glycocalyx, a protective coat that enhances the stability and flexibility of cell membranes and defends against physical and chemical damage.

Glycans also interact with intracellular proteins and participate in cytoskeleton formation. They provide robust mechanical support to maintain the normal morphology and structure of cells.
Immune Regulation
Glycans act as ligands for receptors and chemokines on certain immune cells to regulate the activity and functions of immune cells. For example, specific glycans can enhance the cytotoxicity of NK cells and help eliminate virus-infected and tumor cells.

Specific glycan structures exist on the surface of foreign pathogens. The human immune system recognizes these structures and activates immune responses to generate corresponding antibodies and immune cells for anti-infection defense.
Substance Transport & Metabolism
Inside cells, glycans modify proteins and lipids to form glycosylated products. Guided by glycan chain signals, these substances are accurately transported and localized to specific organelles such as the endoplasmic reticulum and Golgi apparatus for subsequent processing.

Cell surface glycoproteins function as transporters. They bind with nutrients and facilitate their entry into cells, supplying energy and materials to sustain cellular activities.
Development of Global
Bloomage Biotech driving the Development of
Global Glycobiology Industry
2003
GlycoMimetics, a biotechnology company dedicated to the research and development of anti-tumor glyco-drugs, was founded.
Meanwhile, hyaluronic acid was approved by the FDA as an ingredient for aesthetic wrinkle treatment.
2005
Leading pharmaceutical enterprises accelerated the layout of glycobiology: Roche acquired GlycArt, a company that optimizes antibody efficacy through glycan modification of antibodies; Merck acquired GlycoFi, which specializes in producing recombinant human proteins with complex glycosylation.
2012
The U.S. National Research Council released the national strategic document Translating Glycoscience: A Roadmap for the Future, designating glycobiology as a key development direction for life sciences, pharmaceuticals and energy industries.
2015
The industry explored glycan editing for the treatment of cancer and autoimmune diseases. High-precision HA-based 3D printing substrates advanced the development of tissue engineering.
2020–Present
With the establishment of glycan databases and the improvement of AI computing power, the "cellular fingerprint" code of glycans has been gradually deciphered. This drives the transformation of traditional medicine toward personalized healthcare, especially in the fields of cancer detection, antibody drugs, vaccines and cell therapy.
2023
The market size of glycobiology-related pharmaceuticals and medical devices in China reached 8 billion US dollars, accounting for 16% of the global total. The glycobiology industry still boasts enormous development potential.
2001
2003
2005
2007
2011
2012
2015
2017
2018
2020
2021
2022
2023
2001
Bloomage Group invested in the fermentation production technology of pharmaceutical-grade hyaluronic acid.
2003
Bloomage Biotech adopted microbial fermentation technology to resolve the low yield problem of HA produced via animal extraction.
2007
Bloomage Biotech became the world's largest manufacturer of hyaluronic acid raw materials by market share.
2011
Bloomage Biotech pioneered the enzymatic cleavage technology and realized the production of hyaluronic acid with precise molecular weights.
2017
Bloomage Biotech acquired Revitacare of France along with its core Cytocare cellular revitalizing technology, laying a solid foundation for the company's future development in cell biology.
2018
Bloomage Biotech invested in and built the world's largest synthetic biology pilot transformation platform. We completed the fourth iteration of hyaluronic acid production processes based on synthetic biology fermentation technology.
2021
China accounts for 82% of the world's total hyaluronic acid output,
among which Bloomage Biotech contributes 44% of the global supply.
2022
Bloomage Biotech established cooperation with Japan's BMS and Rohto Pharmaceutical. By studying the impact of HA on stem cell differentiation, we began to explore the regulatory effects of glycans on cells.
2023
Bloomage Biotech realized the commercial production of BloomStem and two other self-developed animal-free cell culture media.